ZEB2 and melanoma: In line with Denecker [38], which showed ZEB1 and ZEB2 inverse modulation and the presence of ZEB2 as a positive prognostic factor for melanoma patients, we observed the SCD5-dependent up-regulation of ZEB2 paralleled by reduced amounts of ZEB1 (Figure 6A, 6B).